23andMe Holding Co - Warrants (16/06/2026) Current Cash

The latest current cash for MEUSW is $40M as of June 2025. That compares with $170M in the prior-year period — down 76.6% year over year. Investors often review this figure alongside 23andMe Holding Co - Warrants (16/06/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MEUSW's current cash moved from $170M to $40M — a 76.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 23andMe Holding Co - Warrants (16/06/2026)'s operating scale or balance-sheet position.

A current cash figure of $40M for MEUSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MEUSW's current cash ($40M), review year-over-year change from $170M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 23andMe Holding Co - Warrants (16/06/2026)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.